Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Otsuka Pharmaceutical
Pharmaceutical Preparation ManufacturingJapan
Last verified 5 months agootsuka.com
Otsuka Pharmaceutical Co., Ltd., a leading name in the pharmaceutical preparation manufacturing industry, is headquartered in Japan (JP) and operates extensively across Asia, Europe, and the Americas. Founded in 1921, Otsuka has established itself as a pioneer in innovative healthcare solutions, focusing on areas such as mental health, nephrology, and oncology.
The company is renowned for its unique products, including the groundbreaking antipsychotic medication Abilify and the hydration solution Pocari Sweat, which have significantly impacted patient care and wellness. Otsuka's commitment to research and development has positioned it as a formidable player in the global pharmaceutical market, with notable achievements in drug discovery and patient-centric solutions. Through its dedication to improving health outcomes, Otsuka continues to shape the future of healthcare.
53
DitchCarbon score
+11 vs industry average
Otsuka Pharmaceutical’s score of 53 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Otsuka Pharmaceutical?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
High
Pharmaceutical Preparation Manufacturing has above-average carbon intensity
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2027
20202021202220232024202520262027
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Otsuka Pharmaceutical's reported carbon emissions
Otsuka Pharmaceutical reported total emissions of approximately 527 million kg CO2e in 2024. This included about 368.7 million kg CO2e from Scope 1 emissions and approximately 188.8 million kg CO2e from Scope 2 emissions.
The company has set a near-term target to reduce its Scope 1 and 2 CO2 emissions by 50% by 2028, against a 2017 baseline. This target was accelerated from an earlier 2030 goal in 2022. Additionally, Otsuka Pharmaceutical aims for carbon neutrality for its Scope 3 emissions by 2050 as part of its "Net Zero" 2050 Environmental Vision, which seeks to reduce the total environmental impact across all business activities to zero.
Otsuka Holdings Co., Ltd., the parent organisation, has a near-term Science Based Targets initiative (SBTi) commitment.
Assessing Otsuka Pharmaceutical as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Otsuka Pharmaceutical and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Otsuka Pharmaceutical’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
6 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
See details
Active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
2050 targetSee details
Active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Otsuka Pharmaceutical5 months ago
53
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Frequently asked questions
Common questions about Otsuka Pharmaceutical’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more